| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5645035 | Annals of Allergy, Asthma & Immunology | 2017 | 6 Pages |
Abstract
As epinephrine autoinjector technology continues to evolve, device characteristics that promote safe, user-friendly experiences and give clinicians and their patients confidence to successfully treat anaphylaxis during an emergency, without injury, will be favored.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Paul A. MD, Dana V. MD, Phillip L. MD, Sean M. PhD,